Genetic Association Studies Identify Unanticipated Gene Pathways Influencing Sepsis Outcome

by Keith R. Walley
Published 2016-10-01

Sepsis breakthroughs in 2014 [v1; ref status: indexed, http://f1000r.es/5ft]

by James A. Russell, Keith R. Walley
Published 2015-05-01

Vasopressin versus norepinephrine in septic shock: a propensity score matched efficiency retrospective cohort study in the VASST coordinating center hospital

by James A. Russell, Hugh Wellman, Keith R. Walley
Published 2018-11-01

S-nitrosoglutathione acts as a small molecule modulator of human fibrin clot architecture.

by Ryon M Bateman, Christopher G Ellis, Makoto Suematsu, Keith R Walley
Published 2012-01-01

Significance of lactate clearance in septic shock patients with high bilirubin levels

by Nozomi Takahashi, Taka-aki Nakada, Keith R. Walley, James A. Russell
Published 2021-03-01

Cytokines and signaling molecules predict clinical outcomes in sepsis.

by Christopher D Fjell, Simone Thair, Joseph L Hsu, Keith R Walley, James A Russell, John Boyd
Published 2013-01-01

Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor.

by Elena Topchiy, Mihai Cirstea, HyeJin Julia Kong, John H Boyd, Yingjin Wang, James A Russell, Keith R Walley
Published 2016-01-01

Correction: Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor.

by Elena Topchiy, Mihai Cirstea, HyeJin Julia Kong, John H Boyd, Yingjin Wang, James A Russell, Keith R Walley
Published 2016-01-01

Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis

by Joseph G. H. Lee, Kelly R. Genga, Chawika Pisitsak, John H. Boyd, Alex K. K. Leung, James A. Russell, Keith R. Walley
Published 2018-03-01

Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivorsResearch in context

by Kelly Roveran Genga, Cody Lo, Mihai S. Cirstea, Fernando Sergio Leitao Filho, Keith R. Walley, James A. Russell, Adam Linder, Gordon A. Francis, John H. Boyd
Published 2018-12-01

Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

by Manoj M Lalu, Katrina J Sullivan, Shirley HJ Mei, David Moher, Alexander Straus, Dean A Fergusson, Duncan J Stewart, Mazen Jazi, Malcolm MacLeod, Brent Winston, John Marshall, Brian Hutton, Keith R Walley, Lauralyn McIntyre, on behalf of the Canadian Critical Care Translational Biology Group
Published 2016-11-01

Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis

by Mary Thompson, Shirley H.J. Mei, Dianna Wolfe, Josée Champagne, Dean Fergusson, Duncan J. Stewart, Katrina J. Sullivan, Emily Doxtator, Manoj Lalu, Shane W. English, John Granton, Brian Hutton, John Marshall, Alies Maybee, Keith R. Walley, Claudia Dos Santos, Brent Winston, Lauralyn McIntyre
Published 2020-02-01

Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis

by Djillali Annane, Jean-Paul Mira, Lorraine B. Ware, Anthony C. Gordon, Charles J. Hinds, David C. Christiani, Jonathan Sevransky, Kathleen Barnes, Timothy G. Buchman, Patrick J. Heagerty, Robert Balshaw, Nadia Lesnikova, Karen de Nobrega, Hugh F. Wellman, Mauricio Neira, Alexandra D. J. Mancini, Keith R. Walley, James A. Russell
Published 2018-01-01

Erratum to: Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine

by Sangeeta Mehta, John Granton, Anthony C. Gordon, Deborah J. Cook, Stephen Lapinsky, Gary Newton, Kris Bandayrel, Anjuli Little, Chuin Siau, Dieter Ayers, Joel Singer, Terry C. K. Lee, Keith R. Walley, Michelle Storms, D. James Cooper, Cheryl L. Holmes, Paul Hebert, Jeffrey Presneill, James A. Russell, for the Vasopressin and Septic Shock Trial (VASST) Investigators
Published 2017-05-01

Significance of body temperature in elderly patients with sepsis

by Takashi Shimazui, Taka-aki Nakada, Keith R. Walley, Taku Oshima, Toshikazu Abe, Hiroshi Ogura, Atsushi Shiraishi, Shigeki Kushimoto, Daizoh Saitoh, Seitaro Fujishima, Toshihiko Mayumi, Yasukazu Shiino, Takehiko Tarui, Toru Hifumi, Yasuhiro Otomo, Kohji Okamoto, Yutaka Umemura, Joji Kotani, Yuichiro Sakamoto, Junichi Sasaki, Shin-ichiro Shiraishi, Kiyotsugu Takuma, Ryosuke Tsuruta, Akiyoshi Hagiwara, Kazuma Yamakawa, Tomohiko Masuno, Naoshi Takeyama, Norio Yamashita, Hiroto Ikeda, Masashi Ueyama, Satoshi Fujimi, Satoshi Gando, on behalf of the JAAM FORECAST Group
Published 2020-06-01

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors

by Terry Lee, PhD, Alessandro Cau, BSc, Matthew Pellan Cheng, MD, Adeera Levin, MD, Todd C. Lee, MD, Donald C. Vinh, MD, Francois Lamontagne, MD, Joel Singer, PhD, Keith R. Walley, MD, Srinivas Murthy, MD, David Patrick, MD, Oleksa G. Rewa, MD, Brent W. Winston, MD, John Marshall, MD, John Boyd, MD, Karen Tran, MD, Andre C. Kalil, MD, Russell Mcculoh, MD, Robert Fowler, MD, James M. Luther, MD, James A. Russell, MD
Published 2021-07-01

Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model

by Beth A. Payne, Helen Ryan, Jeffrey Bone, Laura A. Magee, Alice B. Aarvold, J. Mark Ansermino, Zulfiqar A. Bhutta, Mary Bowen, J. Guilherme Cecatti, Cynthia Chazotte, Tim Crozier, Anne-Cornélie J. M. de Pont, Oktay Demirkiran, Tao Duan, Marlot Kallen, Wessel Ganzevoort, Michael Geary, Dena Goffman, Jennifer A. Hutcheon, K. S. Joseph, Stephen E. Lapinsky, Isam Lataifeh, Jing Li, Sarka Liskonova, Emily M. Hamel, Fionnuala M. McAuliffe, Colm O’Herlihy, Ben W. J. Mol, P. Gareth R. Seaward, Ramzy Tadros, Turkan Togal, Rahat Qureshi, U. Vivian Ukah, Daniela Vasquez, Euan Wallace, Paul Yong, Vivian Zhou, Keith R. Walley, Peter von Dadelszen, the CIPHER Group
Published 2018-10-01